Daniela A Riano Barros
Overview
Explore the profile of Daniela A Riano Barros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangoo S, Erridge S, Holvey C, Coomber R, Barros D, Bhoskar U, et al.
Expert Rev Neurother
. 2022 Dec;
22(11-12):995-1008.
PMID: 36573268
Background: Although pre-clinical experiments associate cannabinoids with reduced depressive symptoms, there is a paucity of clinical evidence. This study aims to analyze the health-related quality of life changes and safety...
2.
Erridge S, Kerr-Gaffney J, Holvey C, Coomber R, Barros D, Bhoskar U, et al.
Ther Adv Psychopharmacol
. 2022 Sep;
12:20451253221116240.
PMID: 36159065
Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical...
3.
McGinnity C, Barros D, Guedj E, Girard N, Symeon C, Walker H, et al.
Front Neurosci
. 2021 Jul;
15:664525.
PMID: 34220424
We retrospectively examined the relationship between blood biomarkers, in particular the historical mean phenylalanine to tyrosine (Phe:Tyr) ratio, and cerebral glucose metabolism. We hypothesized that the historical mean Phe:Tyr ratio...
4.
McGinnity C, Barros D, Hinz R, Myers J, Yaakub S, Thyssen C, et al.
Brain Commun
. 2021 Jan;
3(1):fcaa190.
PMID: 33501420
GABA receptors containing the α5 subunit mediate tonic inhibition and are widely expressed in the limbic system. In animals, activation of α5-containing receptors impairs hippocampus-dependent memory. Temporal lobe epilepsy is...
5.
McGinnity C, Arstad E, Beck K, Brooks D, Coles J, Duncan J, et al.
ACS Chem Neurosci
. 2018 Oct;
10(1):768-772.
PMID: 30346706
Schoenberger and colleagues ( Schoenberger et al. ( 2018 ) ACS Chem. Neurosci. 9 , 298 - 305 ) recently reported attempts to demonstrate specific binding of the positron emission...
6.
McGinnity C, Barros D, Trigg W, Brooks D, Hinz R, Duncan J, et al.
EJNMMI Res
. 2018 Jun;
8(1):46.
PMID: 29892810
Introduction: The NMDA receptor radiotracer [F]GE-179 has been used with 90-min scans and arterial plasma input functions. We explored whether (1) arterial blood sampling is avoidable and (2) shorter scans...
7.
McGinnity C, Barros D, Rosso L, Veronese M, Rizzo G, Bertoldo A, et al.
Neuroimage
. 2017 Mar;
152:270-282.
PMID: 28292717
Introduction: Alteration of γ-aminobutyric acid "A" (GABA) receptor-mediated neurotransmission has been associated with various neurological and psychiatric disorders. [C]Ro15-4513 is a PET ligand with high affinity for α5-subunit-containing GABA receptors,...
8.
Barros D, McGinnity C, Rosso L, Heckemann R, Howes O, Brooks D, et al.
Neuroimage
. 2014 Apr;
97:151-62.
PMID: 24736184
Background: Endocannabinoids are involved in normal cognition, and dysfunction in cannabinoid-receptor-mediated neurotransmission has been suggested in a variety of neurological and psychiatric pathologies. The type 1 cannabinoid receptor (CB1) is...
9.
Initial evaluation of 18F-GE-179, a putative PET Tracer for activated N-methyl D-aspartate receptors
McGinnity C, Hammers A, Barros D, Luthra S, Jones P, Trigg W, et al.
J Nucl Med
. 2014 Feb;
55(3):423-30.
PMID: 24525206
Unlabelled: N-methyl D-aspartate (NMDA) ion channels play a key role in a wide range of physiologic (e.g., memory and learning tasks) and pathologic processes (e.g., excitotoxicity). To date, suitable PET...
10.
McGinnity C, Shidahara M, Feldmann M, Keihaninejad S, Barros D, Gousias I, et al.
Neuroimage
. 2013 Apr;
79:72-80.
PMID: 23597934
Previous positron emission tomography (PET) studies in refractory temporal lobe epilepsy (TLE) using the non-selective opioid receptor antagonist [(11)C]diprenorphine (DPN) did not detect any changes in mesial temporal structures, despite...